Xenetic Biosciences Inc, Baxter deal

By WIR Staff | Feb 10, 2014 | 8:00 AM GMT

The partners amended a 2005 deal under which Xenetic (formerly Lipoxen plc) granted Baxter exclusive rights to Xenetic's polysialic acid (PSA) technology in